Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2026-06-12 21:07:46 ET · period of report 2026-06-11 · accession 0001628280-26-043009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-12 21:07 | 2026-06-11 | PCRX | RIKER LAUREN | SVP, Fin | S - Sale | $23.50 | -6,115 | 62.3K | -9% | -$143.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-11 | S | D | 6,115 | $23.50 | 62,284.24 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026. |